We then hypothesized that TYMS rs3786362 might have important effects on PFS and OS in mCRC patients and could be a predictive biomarker for survival of mCRC patients in subgroups of younger age, well and moderate tumor differentiation, with metastatic organism ≤ 2 and non-smoking status. The gene discussed is TYMS; the disease is neoplasm.